Efficacy and Safety of Tonabersat, a Gap-Junction Modulator, in the Acute Treatment of Migraine: A Double-Blind, Parallel-group, Randomized Study

Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Study of the Cortical Spreading Depression Inhibiting Agent Tonabersat in Migraine Prophylaxis

(2009) PJ Goadsby et al.   CEPHALALGIA

Tonabersat, a Gap-Junction Modulator: Efficacy and Safety in Two Randomized, Placebo-Controlled, Dose-Ranging Studies of Acute Migraineceph

(2009) SD Silberstein et al.   CEPHALALGIA

Calcitonin gene-related peptide stimulation of nitric oxide synthesis and release from trigeminal ganglion glial cells

(2008) Jing Li et al.   BRAIN RESEARCH

Pharmacology of the short QT syndrome N588K-hERG K+channel mutation: differential impact on selected class I and class III antiarrhythmic drugs

(2008) M J McPate et al.   BRITISH JOURNAL OF PHARMACOLOGY

Progress report on new antiepileptic drugs: A summary of the Ninth Eilat Conference (EILAT IX)

(2008) Meir Bialer et al.   EPILEPSY RESEARCH

Clinical and Preclinical Rationale for CGRP-Receptor Antagonists in the Treatment of Migraine

(2008) Stewart J. Tepper et al.   HEADACHE

Inhibition of Calcitonin Gene-Related Peptide Function: A Promising Strategy for Treating Migraine

(2008) Paul L. Durham   HEADACHE

Migraine with and without aura share the same pathogenic mechanisms

(2008) R. Allan Purdy   NEUROLOGICAL SCIENCES

Calcitonin gene-related peptide (CGRP) antagonists and migraine: Is this a new era?

(2008) P. J. Goadsby   NEUROLOGY